Why and how to involve rare disease patients in the evaluation process of a new health tec... 27/02/2024 Healthcare Rare diseases Innovative drugs Personalized medicine Advanced therapies Alira Health experts explain in an interview the importance of involving patients with rare diseases in the evaluation... Partners
BCN HEALTH publishes a study evaluating hospital incidence and medical costs associated wi... 26/02/2024 Healthcare Rare diseases BCN HEALTH has published the study "Incidence and medical costs of lupus in Spanish hospitals: a retrospective database... Partners - BCN Health
The Ministry of Health presents the new Common Catalog of Genetic and Genomic Tests of the... 24/01/2024 Healthcare Rare diseases Personalized medicine Advanced therapies The catalog, which currently includes 672 tests, will continue to be progressively expanded due to its 'flexible' nature... AseBio
ORYZON to Host KOL Event on Phase IIb PORTICO Topline Study Results of Vafidemstat in Bord... 19/01/2024 Healthcare Rare diseases Innovative drugs The event will feature a brief review of the topline results of the Phase IIb PORTICO study, then a discussion with... Partners - Oryzon Genomics
SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting... 17/10/2023 Healthcare Drug discovery Rare diseases Advanced therapies Spark secures exclusive worldwide rights to SpliceBio’s proprietary Protein Splicing platform to develop, manufacture... Partners - Asabys Partners
ZIP Solutions and YIMA Announce Strategic Co-Marketing Agreement for Gene Therapy 05/06/2023 Healthcare Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies International ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech... Partners - Biotechnology Assets
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and ... 24/03/2023 Healthcare Access to innovation In vitro diagnostics Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies Gene editing International The tool has many biotech applications Partners - Biotechnology Assets
OLIGOFASTX consortium shares at Farmaforum the progress of the project after 1 year of wor... 06/10/2022 Drug discovery Rare diseases Innovative drugs Industrial biotechnology They have organized the round table "End-to-end technological solution for the development of oligonucleotide-based... Partners
DR Healtchare lanza la campaña “Me Again” para dar a conocer el déficit de DAO 9 junio, 20... 16/06/2022 Healthcare Rare diseases DR Healthcare se prepara para el lanzamiento de su nueva campaña de comunicación sobre el déficit de DAO Partners - DR Healthcare
